Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Biogen hired Dr. Michael Ehlers as executive vice president, R&D. Previously, he worked at Pfizer where he was group senior vice president for BioTherapeutics R&D and chief scientific officer for the neuroscience and pain research unit.
Orexigen Therapeutics hired Beth Eastland as vice president of sales;
GlaxoSmithKline Consumer Healthcare hired Sawan Malik as executive vice president of sales in India;
GlaxoSmithKline Consumer Healthcare named Siddharth Singh as VP, commercial excellence for the AMA region;
PTC Therapeutics promoted Dr. Tuyen Ong to chief medical officer;
Astellas hired Rodrigo Fernandez as executive director, international business;
Astellas promoted Mark Wanda to executive director, anti-bribery and anti-corruption;
Astellas promoted Nahrin Marino to deputy general counsel;
Pliant Therapeutics hired Hans Hull as chief business officer;
Pliant Therapeutics hired Randall Halcomb as vice president of medicinal chemistry;
Pliant Therapeutics hired Patrick Andre as vice president of biology;
Synergy Pharmaceuticals said that Gary Sender resigned as chief financial officer;
Synergy Pharmaceuticals named Bernard Denoyer as principal financial officer.